Professor Paul Haber

Area Medical Director, Drug Health Services
Addiction Medicine, Central Clinical School

Telephone +61 2 9515 6419
Fax +612 9515 8970

Map

Research interests

Alcoholic liver disease, drugs and alcohol, alcohol metabolism, hepatitis C

Selected grants

2014

  • Mixed methods evaluation of new psychiatric short stay unit service; Glozier N, Haber P; Sydney Local Health District/Research Support.
  • Improving alcohol treatment outcomes: the impact of client, intervention and system variables on treatment outcomes.; Sanson-Fisher R, Shakeshaft A, Farrell M, Mattick R, Bryant J, D'Este C, Haber P; National Health and Medical Research Council (NHMRC)/Project Grants.

2013

  • Sydney Neuroscience Network; Balleine B, Absalom N, Braddon-Mitchell D, Callaghan S, Chawla S, Christie M, Collins M, Einfeld S, Grieve S, Haber P, Hanrahan J, Harris A, Hickie I, Kassiou M, Kril J, Meikle S, Morris R, Ramos F, Rong Y, Sue C; DVC Research/Research Network Scheme (SyReNS).

2012

  • CRE in Mental Health and Substance Use: Translating innovative prevention and treatment; Teesson M, Baker A, Mills K, Kay-Lambkin F, Haber P, Baille A, Christensen H, Birchwood M, Spring B, Brady K; National Health and Medical Research Council (NHMRC)/Centres of Research Excellence.

2011

  • Genetic risk factors for alcoholic cirrhosis - genome wide case control study; Seth D, Haber P, Nalpas B, Stickel F, Day C, Lumeng L, Morgan T, Whitfield J; National Institutes of Health (USA)/Research Support.
  • Exploring the efficacy and biobehavioural basis of Baclofen in the treatment of alcoholic liver disease.; Haber P, Baille A; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Development and implementation of consensus statewide clinical indicators for drugs in pregnancy services; Haber P; Health Administration Corporation/Research Support.
  • The safety and efficacy of extended-release naltrexone: An Australian Pilot Study; Morley K, Haber P; Alcohol Education and Rehabilitation Foundation/Research Grant.

2009

  • The effects of mixing alcohol with presciption drugs upon driving performance: a randomised simulator study; Lintzeris N, Leung S, Lenne M, Haber P, Bruno R; National Health and Medical Research Council (NHMRC)/Project Grants.

2008

  • Genetic Determinants of the response to pharmacotherapy for alcohol dependence; Morley K, Haber P; Health Administration Corporation/Drug and Alcohol Research Grant.
  • Career Awards: Practitioner Fellowship; Haber P; National Health and Medical Research Council (NHMRC)/Career Awards: Practitioner Fellowships.

2007

  • Novel treatments for young people with harmful alcohol use: A randomised controlled trial of structured stepped-care intervention for psychiatric comorbidity; Haber P; NSW Health - The Health Administration Corporation/Research Grant.

2005

  • Novel treatments for alcohol dependence: a randomised trial of structured stepped-care intervention for psychiatric comorbidity; Haber P; Alcohol Education and Rehabilitation Foundation/Research Grant.

2003

  • Molecular Pathogenesis of alcoholic liver disease; Haber P, Gorrell M, McCaughan G; Hlth & Medical Research Grants/Research Grant.

2002

  • The role of pharmacotherapy in prevention of relapse in alcohol dependence; Haber P, Hall W, Bell J, Teesson M; National Health and Medical Research Council (NHMRC)/Project Grants.

2001

  • Microarray analysis of intrahepatic gene expression in alcoholic liver disease; Haber P; DVC Research/Research and Development Scheme: Newly Appointed Staff (NAS).
  • The role of pharmacotherapy in prevention of relapse in alcohol dependence; Haber P; DVC Research/Bridging Support Grant.

2000

  • Randomised control trial of a tailored intervention to improve alcohol related outcomes following elective surgery; Haber P; Department of Veterans' Affairs/Research Grant.

1999

  • Use of intrahepatic markers of endotoxin- and oxidant stress-related toxicity to evaluate the prognosis of human alcoholic liver disease; Haber P; Clive & Vera Ramaciotti Foundation/Research Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Lakshman, M., Garige, M., Gong, M., Leckey, L., Varatharajalu, R., Redman, R., Seth, D., Haber, P., Hirsch, K., Amdur, R., et al (2013). CYP2E1, Oxidative Stress, Post-translational Modifications and Lipid Metabolism. In Aparajita Dey (Eds.), Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism, (pp. 199-233). Dordrecht: Springer Science + Business Media.
  • Haber, P. (2011). Gastrointestinal disorders related to alcohol and other drug use. In Christopher A. Cavacuiti (Eds.), Principles of Addiction Medicine: The Essentials, (pp. 0-0). United States: Lippincott Williams & Wilkins.
  • Haber, P., Batey, R. (2011). Liver disorders related to alcohol and other drug use. In Christopher A. Cavacuiti (Eds.), Principles of Addiction Medicine: The Essentials, (pp. 0-0). United States: Lippincott Williams & Wilkins.
  • Haber, P., Neasham, K. (2009). Alcohol and Drug Abuse. In T Declan Walsh, Augusto T Caraceni, etal (Eds.), Palliative Medicine (2009), (pp. 451-458). United States: Saunders Elsevier.
  • Day, C., Haber, P. (2009). Managing drug dependence in people with hepatitis C. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 288-307). East Hawthorn, Victoria: IP Communications.
  • Haber, P., Lintzeris, N., Morley, K. (2009). Pharmacotherapies for alcohol dependence. In Paul Haber, Elizabeth Proude, Nick Lintzeris & Olga Lopatko (Eds.), Guidelines for the Treatment of Alcohol Problems, (pp. 93-106). Australia: Commonwealth of Australia.
  • Shourie, S., Haber, P., Boughton, R., Conigrave, K. (2005). Clinical implications of alcohol misuse for surgery. In Preedey V; Watson R (Eds.), Comprehensive handbook of alcohol related pathology, (pp. 337-348). United States: Academic Press Elsevier.

Journals

  • Keane, F., Tsun-Wen, Y., Seelk, S., Gall, M., Chowdhury, S., Poplawski, S., Lai, J., Li, Y., Wu, W., Farrell, P., Vieira de Ribeiro, A., Osborne, B., Yu, M., Seth, D., Haber, P., Wang, C., Thomson, S., Twigg, S., McLennan, S., McCaughan, G., Gorrell, M., et al (2014). Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio, 4, 43-54. [More Information]
  • Morley, K., Sitharthan, G., Haber, P., Tucker, P., Sitharthan, T. (2014). The Efficacy of an Opportunistic Cognitive Behavioral Intervention Package (OCB) on Substance Use and Comorbid Suicide Risk: A Multisite Randomized Controlled Trial. Journal of Consulting and Clinical Psychology, 82(1), 130-140. [More Information]
  • Islam, M., Conigrave, K., Day, C., Nguyen, Y., Haber, P. (2014). Twenty-year trends in benzodiazepine dispensing in the Australian population. Internal Medicine Journal, 44(1), 57-64. [More Information]
  • Topp, L., Day, C., Wand, H., Deacon, R., Van Beek, I., Haber, P., Shanahan, M., Rodgers, C., Maher, L. (2013). A randomised controlled trial of �?nancial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine, 57(4), 297-303. [More Information]
  • Baille, A., Sannibale, C., Stapinski, L., Teesson, M., Rapee, R., Haber, P. (2013). An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol. BMC Psychiatry, 13(7), 1-12. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Haber, P., Day, C. (2013). Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. International Journal of Drug Policy, 24(4), 326-332. [More Information]
  • Alavi, M., Grebely, J., Micallef, M., Dunlop, A., Balcomb, A., Day, C., Treloar, C., Bath, N., Haber, P., Dore, G. (2013). Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study. Clinical Infectious Diseases, 57(Suppl 2), S62-S69. [More Information]
  • Morley, K., Baillie, A., Sannibale, C., Teesson, M., Haber, P. (2013). Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial. Addiction Science & Clinical Practice, 8, 1-8. [More Information]
  • Buckley, V., Razaghi, A., Haber, P. (2013). Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service. Australian and New Zealand Journal of Obstetrics and Gynaecology, 53(5), 464-470. [More Information]
  • Islam, M., Topp, L., Conigrave, K., Haber, P., White, A., Day, C. (2013). Sexually transmitted infections, sexual risk behaviours and perceived barriers to safe sex among drug users. Australian and New Zealand Journal of Public Health, 37(4), 311-315. [More Information]
  • Morley, K., Leung, S., Baillie, A., Haber, P. (2013). The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial. Contemporary Clinical Trials, 36(2), 348-355. [More Information]
  • Taylor, L., Hutchinson, D., Rapee, R., Burns, L., Stephens, C., Haber, P. (2012). Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service. Obstetrics and Gynecology International, 2012, 1-8. [More Information]
  • Deacon, R., Topp, L., Wand, H., Day, C., Rodgers, C., Haber, P., van Beek, I., Maher, L. (2012). Correlates of Susceptibility to Hepatitis B among People Who Inject Drugs in Sydney, Australia. Journal of Urban Health, 89(5), 769-778. [More Information]
  • Schwarz, B., Haber, P. (2012). Detection and management of problem drinking in general practice. Medicine Today, 13(7), 44-52.
  • Alavi, M., Grebely, J., Matthews, G., Petoumenos, K., Yeung, B., Day, C., Lloyd, A., van Beek, I., Kaldor, J., Hellard, M., Haber, P., et al (2012). Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27(5), 957-965. [More Information]
  • Gidding, H., Law, M., Amin, J., Ostapowicz, G., Weltman, M., Macdonald, G., Sasadeusz, J., Haber, P., George, J., Dore, G. (2012). Hepatitis C treatment outcomes in Australian clinics. Medical Journal of Australia, 196(10), 633-637. [More Information]
  • Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012). Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review, 31(4), 499-506. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Reid, S., Grummett, S., Haber, P., Day, C. (2012). Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Journal of Substance Abuse Treatment, 43(4), 440-445. [More Information]
  • Black, K., Haber, P., Lintzeris, N. (2012). Offering incentives to drug-using women to take up contraception: The ethical and clinical issues. Addiction, 107(7), 1361-1362. [More Information]
  • Mofizul Islam, M., Reid, S., White, A., Grummett, S., Conigrave, K., Haber, P. (2012). Opportunistic and continuing health care for injecting drug users from a nurse-run needle syringe program-based primary health-care clinic. Drug and Alcohol Review, 31(1), 114-115. [More Information]
  • Morley, K., Haber, P., Morgan, M., Samara, F. (2012). Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Substance Abuse and Rehabilitation, 3, 43-47. [More Information]
  • Black, K., Stephens, C., Haber, P., Lintzeris, N. (2012). Unplanned pregnancy and contraceptive use in women attending drug treatment services. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(2), 146-150. [More Information]
  • Mofizul Islam, M., Grummett, S., White, A., Reid, S., Day, C., Haber, P. (2011). A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health, 35(3), 294-295. [More Information]
  • Grebely, J., Matthews, G., Hellard, M., Shaw, D., van Beek, I., Petoumenos, K., Alavi, M., Yeung, B., Haber, P., Lloyd, A., et al (2011). Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of Hepatology, 55(1), 76-85. [More Information]
  • Day, C., Mofizul Islam, M., White, A., Reid, S., Hayes, S., Haber, P. (2011). Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Australian Journal of Primary Health, 17(1), 10-15. [More Information]
  • Haber, P. (2011). International perspectives in postgraduate medical training in addiction medicine. Substance Abuse, 32(2), 75-76. [More Information]
  • Seth, D., Haber, P., Syn, W., Diehl, A., Day, C. (2011). Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances. Journal of Gastroenterology and Hepatology, 26(7), 1089-1105. [More Information]
  • Demirkol, A., Haber, P., Conigrave, K. (2011). Problem drinking - detection and assessment in general practice. Australian Family Physician, 40(8), 570-574. [More Information]
  • Demirkol, A., Conigrave, K., Haber, P. (2011). Problem drinking - management in general practice. Australian Family Physician, 40(8), 576-582. [More Information]
  • Burns, L., Conroy, E., Moore, E., Hutchinson, D., Haber, P. (2011). Psychosocial Characteristics and Obstetric Health of Women Attending a Specialist Substance Use Antenatal Clinic in a Large Metropolitan Hospital. International Journal of Pediatrics, 2011 (Article ID 729237), 1-7. [More Information]
  • Haber, P., Murnion, B. (2011). Training in Addiction Medicine in Australia. Substance Abuse, 32(2), 115-119. [More Information]
  • Lipworth, W., Wodak, A., Haber, P., Day, R. (2011). Why is Disulfiram not on the PBS? Medical Journal of Australia, 195(7), 371-372. [More Information]
  • Seth, D., El-Guindy, N., Apte, M., Mari, M., Dooley, S., Neuman, M., Haber, P., Kundu, G., Darwanto, A., De Villiers, W., et al (2010). Alcohol, Signaling, and ECM Turnover. Alcoholism: Clinical and Experimental Research, 34(1), 1-15. [More Information]
  • Morley, K., Teesson, M., Sannibale, C., Baillie, A., Haber, P. (2010). Clinical Predictors of Outcome from an Australian Pharmacological Relapse Prevention Trial. Alcohol and Alcoholism, 45, 520-526. [More Information]
  • Dore, G., Hellard, M., Matthews, G., Grebely, J., Haber, P., Petoumenos, K., Yeung, B., Marks, P., van Beek, I., McCaughan, G., et al (2010). Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology, 138(1), 123-135.e1-2. [More Information]
  • Boonwaat, L., Haber, P., Levy, M., Lloyd, A. (2010). Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Medical Journal of Australia, 192(9), 496-500. [More Information]
  • Grebely, J., Petoumenos, K., Matthews, G., Haber, P., Marks, P., Lloyd, A., Kaldor, J., Dore, G., Hellard, M. (2010). Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug and Alcohol Dependence, 107(40239), 244-249. [More Information]
  • Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010). Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review, 29(5), 469-474. [More Information]
  • Dolan, K., Teutsch, S., Scheuer, N., Levy, M., Rawlinson, W., Kaldor, J., Lloyd, A., Haber, P. (2010). Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal Of Epidemiology, 25(2), 143-148. [More Information]
  • Teutsch, S., Luciani, F., Scheuer, N., McCredie, L., Hosseiny, P., Rawlinson, W., Kaldor, J., Dore, G., Dolan, K., Ffrench, R., Haber, P., et al (2010). Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health, 10(633), 1-9. [More Information]
  • Seth, D., Daly, A., Haber, P., Day, C. (2010). Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology, 51(4), 1463-1465. [More Information]
  • Teesson, M., Hall, W., Slade, T., Mills, K., Grove, R., Mewton, L., Baillie, A., Haber, P. (2010). Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction, 105(12), 2085-2094. [More Information]
  • Baillie, A., Stapinski, L., Crome, E., Morley, K., Sannibale, C., Haber, P., Teesson, M. (2010). Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders. Drug and Alcohol Review, 29(5), 518-524. [More Information]
  • Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010). The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction, 105(2), 329-334. [More Information]
  • Matthews, G., Hellard, M., Haber, P., Yeung, B., Marks, P., Baker, D., McCaughan, G., Sasadeusz, J., White, P., Rawlinson, W., et al (2009). Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C. Clinical Infectious Diseases, 48(5), 650-658. [More Information]
  • Leong, M., Murnion, B., Haber, P. (2009). Examination of Opioid Prescribing in Australia from 1992-2007. Internal Medicine Journal, 39(10), 676-681. [More Information]
  • Colagiuri, B., Morley, K., Boakes, R., Haber, P. (2009). Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psychotherapy and psychosomatics, 78(3), 167-171. [More Information]
  • Haber, P., Demirkol, A., Lange, K., Murnion, B. (2009). Management of injecting drug users admitted to hospital. The Lancet, 374(9697), 1284-1293. [More Information]
  • Morley, K., Teesson, M., Sannibale, C., Haber, P. (2009). Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence. Drug and Alcohol Review, 28(3), 222-229.
  • Haber, P., Addolorato, G., Russell, M., Albano, E., Wands, J., Leggio, L. (2009). Understanding and Treating Patients With Alcoholic Cirrhosis: An Update. Alcoholism: Clinical and Experimental Research, 33(7), 1136-1144. [More Information]
  • Devanshi, S., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2008). Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. Journal of Hepatology, 48(4), 614-627. [More Information]
  • Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008). Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction, 103(6), 953-959. [More Information]
  • Gong, M., Castillo, L., Redman, R., Garige, M., Hirsch, K., Azuine, M., Amdur, R., Seth, D., Haber, P., Lakshmanan, M. (2008). Down-regulation of liver Galβ1, 4GlcNAc α2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans. Metabolism: clinical and experimental, 57(12), 1663-1668. [More Information]
  • Proude, E., Conigrave, K., Britton, A., Haber, P. (2008). Improving alcohol and tobacco history taking by junior medical officers. Alcohol and Alcoholism, 43(3), 320-325. [More Information]
  • Neuman, M., Sha, K., Esguerra, R., Zakhari, S., Winkler, R., Hilzenrat, N., Wyse, J., Cooper, C., Seth, D., Gorrell, M., Haber, P., McCaughan, G., et al (2008). Inflammation and Repair in Viral Hepatitis C. Digestive diseases and sciences, 53(6), 1468-1487. [More Information]
  • Thomson, C., Morley, K., Teesson, M., Sannibale, C., Haber, P. (2008). Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug and Alcohol Review, 27(2), 115-122. [More Information]
  • Lane, J., Proude, E., Conigrave, K., de Boer, J., Haber, P. (2008). Nurse-provided screening and brief intervention for risky alcohol consumption by sexual health clinic patients. Sexually Transmitted Infections, 84(7), 524-527. [More Information]
  • Dore, G., Haber, P. (2008). Tell me it ain't so: Patient-to-patient transmission of hepatitis C in an endoscopy clinic. Hepatology (Baltimore Md.), 48(4), 1333-5. [More Information]
  • Williams, G., Daly, M., Proude, E., Kermode, S., Davis, M., Barling, J., Haber, P. (2008). The influence of alcohol and tobacco use in orthopaedic inpatients on complications of surgery. Drug and Alcohol Review, 27(1), 55-64. [More Information]
  • Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J., Haber, P. (2008). Unplanned admissions to two Sydney public hospitals after naltrexone implants. Medical Journal of Australia, 188(8), 441-444. [More Information]
  • Wurst, F., Haber, P., Wiesbeck, G., Watson, B., Wallace, C., Whitfield, J., Halter, C., Weinmann, W., Conigrave, K. (2007). Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study. Addiction Biology, doi:10.1111/j.1369-1600.2007.00076.x, 1-7. [More Information]
  • Shourie, S., Conigrave, K., Proude, E., Haber, P. (2007). Detection of and intervention for excessive alcohol and tobacco use among adult hospital in-patients. Drug and Alcohol Review, 26(2), 127-133. [More Information]
  • Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Vonghia, L., Mirijello, A., Abenavoli, L., D’Angelo, C., Caputo, F., Haber, P., et al (2007). Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. The Lancet, 370(9603), 1915-1922.
  • Watson, B., Conigrave, K., Wallace, C., Whitefield, J., Wurst, F., Haber, P. (2007). Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and Alcohol Review, 26(3), 231-239. [More Information]
  • Shourie, S., Conigrave, K., Proude, E., Ward, J., Wutzke, S., Haber, P. (2007). Pre-operative screening for excessive alcohol consumption among patients scheduled for elective surgery. Drug and Alcohol Review, 26(2), 119-125. [More Information]
  • Haber, P., Young, M., Dorrington, L., Jones, A., Kaldor, J., De Kanzow, S., Rawlinson, W. (2007). Transmission of hepatitis C virus by needle-stick injury in community settings. Journal of Gastroenterology and Hepatology, 22, 1882-1885. [More Information]
  • Haber, P. (2006). Commentary: Challenge for doctors and policy makers. BMJ: British Medical Journal, 332, 277-278.
  • Proude, E., Conigrave, K., Haber, P. (2006). Effectiveness of skills-based training using the Drink-less package to increase family practitioner confidence in intervening for alcohol use disorders. BMC International Health and Human Rights, 6(8), 1-6. [More Information]
  • Seth, D., Gorrell, M., Cordoba, S., McCaughan, G., Haber, P. (2006). Intrahepatic gene expression in human alcoholic hepatitis. Journal of Hepatology, 45(2), 306-320. [More Information]
  • Morley, K., Teesson, M., Reid, S., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J., Richardson, K., Haber, P. (2006). Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction, 101(10), 1451-1462. [More Information]
  • Seth, D., Beard, M., Gorrell, M., McCaughan, G., Haber, P. (2006). Osteopontin: An early marker for alcoholic liver injury? Alcoholism: Clinical and Experimental Research, 30(s2), 89A-89A.
  • Kelly, M., Chick, J., Gribble, R., Gleeson, M., Holton, M., Winstanley, J., McCaughan, G., Haber, P. (2006). Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol and Alcoholism, 41(3), 278-283.
  • Shourie, S., Conigrave, K., Proude, E., Ward, J., Wutzke, S., Haber, P. (2006). The Effectiveness of a Tailored Intervention for Excessive Alcohol Consumption Prior to Elective Surgery. Alcohol and Alcoholism, 41(6), 643-649. [More Information]
  • Richardson, K., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Baillie, A., Haber, P. (2006). The effects of alcohol and naltrexone on craving and alcohol consumption. Alcoholism: Clinical and Experimental Research, 30(s2), 169A-169A.
  • Shackel, N., Seth, D., Haber, P., Gorrell, M., McCaughan, G. (2006). The hepatic transcriptome in human liver disease. Comparative Hepatology, 5, 6-6. [More Information]
  • Teesson, M., Morley, K., Reid, S., Sannibale, C., Thomson, C., Richardson, K., Haber, P. (2006). The influence of depression on pharmacotherapy for alcohol dependence. Alcoholism: Clinical and Experimental Research, 30(s2), 68A-68A.
  • Watson, B., Haber, P., Conigrave, K., Whitfield, J., Wallace, C., Wurst, F. (2005). Alcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatment. Alcoholism: Clinical and Experimental Research, 29(S1), 32A-32A.
  • Seitz, H., Salaspuro, M., Savolainen, M., Haber, P., Ishii, H., Teschke, R., Moshage, H., Lieber, C. (2005). From alcohol toxicity to treatment. Alcoholism: Clinical and Experimental Research, 29(7), 1341. [More Information]
  • Conigrave, K., Proude, E., Haber, P., Wilson, H., Saunders, J. (2005). How to treat - alcohol problems. Australian Doctor, 35(9), 35-42.
  • Reid, S., Teesson, M., Sannibale, C., Matsuda, M., Haber, P. (2005). The Efficacy of Compliance Therapy in Pharmacotherapy for Alcohol Dependence: A Randomized Controlled Trial. Journal of Studies on Alcohol, 66(6), 833-841.
  • Theodorou, S., Haber, P. (2005). The medical complications of heroin use. Current Opinion in Psychiatry, 18(3), 257-263.
  • Post, J., Pan, Y., Freeman, A., Harvey, C., White, P., Palladinetti, P., Haber, P., Marinos, G., Levy, M., Kaldor, J., et al (2004). Clearance Of Hepatitis C Viremia Associated With Cellular Immunity In The Absence Of Seroconversion In The Hepatitis C Incidence And Transmission In Prisons Study Cohort. The Journal of Infectious Diseases, 189(10), 1846-1855.
  • Proude, E., Shourie, S., Conigrave, K., Wutzke, S., Haber, P., Ward, J. (2004). Do Elective Surgery Patients Use The Internet To Look For Information About Their Condition? ANZ Journal of Surgery, 74(5), 304-307.
  • Haber, P. (2004). Genetic disorders in pancreatitis. Journal of Gastroenterology and Hepatology, 19(8), 939-939. [More Information]
  • Gates, J., Post, J., Kaldor, J., Pan, Y., Haber, P., Lloyd, A., Dolan, K. (2004). Risk Factors For Hepatitis C Infection And Perception Of Antibody Status Among Male Prison Inmates In The Hepatitis C Incidence And Transmission In Prisons Study Cohort, Australia. Journal of Urban Health, 81(3), 448-452.
  • Post, J., Yong, W., Freeman, A., Harvey, C., White, P., Palladinetti, P., Marinos, G., Haber, P., Levy, M., Kaldor, J., et al (2003). Clearance of Hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the Hepatitis C incidence and transmission in prisons study cohort. The Journal of Infectious Diseases, 11, 1846-1855.
  • Seth, D., Leo, M., McGuinness, P., Lieber, C., Brennan, Y., Williams, R., Wang, X., McCaughan, G., Gorrell, M., Haber, P. (2003). Gene expression profiling of alcoholic liver disease in the Baboon (Papio hamadryas) and human liver. The American Journal of Pathology: cellular and molecular biology of disease, 163(6), 2303-2317.
  • Fucito, L., Gomes, B., Murnion, B., Haber, P. (2003). General practitioners' diagnostic skills and referral practices in managing patients with drug and alcohol-related health problems: implications for medical training and education programmes. Drug and Alcohol Review, 22(4), 417-424.
  • Haber, P., Conigrave, K., Wodak, A. (2003). NSW Alcohol Summit: getting a better grip on our favourite drug. Medical Journal of Australia, 11, 521-522.
  • Haber, P., Warner, R., Seth, D., Gorrell, M., McCaughan, G. (2003). Pathogenesis and management of alcoholic hepatitis. Journal of Gastroenterology and Hepatology, 18(12), 1332-1344.
  • Seth, D., Gorrell, M., McGuiness, P., Leo, M., Lieber, C., McCaughan, G., Haber, P. (2003). SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. Journal Of Biochemical and Biophysical Methods, 55(1), 53-66.
  • Conigrave, K., Davies, P., Haber, P., Whitfield, J. (2003). Traditional markers of excessive alcohol use. Addiction, 98(S2), 31-43.
  • Haber, P., Nakamura, M., Tsuchimoto, K., Ishii, H., Keogh, G., Apte, M., Moran, C., Stewart, N., Crawford, D., Pirola, R., McCaughan, G., Ramm, G., Conigrave, K., et al (2001). Alcohol and the pancreas. Alcoholism: Clinical and Experimental Research, 25, 244S-250S.

Conferences

  • Morley, K., Haber, P., Sitharthan, G., Tucker, P., Sitharthan, T. (2012). Clinical Predictors of Suicidal Behaviour Among Patients with Alcohol and/or Substance Abuse and Suicide Risk. APSAD Conference, Australasian Professional Society on Alcohol and other Drugs, Melbourne.
  • Haber, P., McCaughan, G., Shaw, D., Matthews, G., Hellard, M., Dore, G., Lloyd, A., Kaldor, J., Rowlinson, W., Ffrench, R. (2007). Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the australian trial in acute hepatitis C (ATAHC). The 58th Annual Meeting of the American Association for the Study of Liver Diseases, United States of America: John Wiley & Sons.
  • Seth, D., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2006). Identification of novel therapeutic targets for alcoholic liver disease. International Society for Biomedical Research on Alcoholism World congress on Alcohol Research (ISBRA 2006), Maryland: Wiley-Blackwell Publishing.
  • Wurst, F., Watson, B., Haber, P., Whitfield, J., Wallace, C., Lauer, J., Weinmann, W., Conigrave, K. (2005). Alcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatment. 24th Symposium of the Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie, Germany: Georg Thieme Verlag.

2014

  • Keane, F., Tsun-Wen, Y., Seelk, S., Gall, M., Chowdhury, S., Poplawski, S., Lai, J., Li, Y., Wu, W., Farrell, P., Vieira de Ribeiro, A., Osborne, B., Yu, M., Seth, D., Haber, P., Wang, C., Thomson, S., Twigg, S., McLennan, S., McCaughan, G., Gorrell, M., et al (2014). Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs. FEBS Open Bio, 4, 43-54. [More Information]
  • Morley, K., Sitharthan, G., Haber, P., Tucker, P., Sitharthan, T. (2014). The Efficacy of an Opportunistic Cognitive Behavioral Intervention Package (OCB) on Substance Use and Comorbid Suicide Risk: A Multisite Randomized Controlled Trial. Journal of Consulting and Clinical Psychology, 82(1), 130-140. [More Information]
  • Islam, M., Conigrave, K., Day, C., Nguyen, Y., Haber, P. (2014). Twenty-year trends in benzodiazepine dispensing in the Australian population. Internal Medicine Journal, 44(1), 57-64. [More Information]

2013

  • Topp, L., Day, C., Wand, H., Deacon, R., Van Beek, I., Haber, P., Shanahan, M., Rodgers, C., Maher, L. (2013). A randomised controlled trial of �?nancial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine, 57(4), 297-303. [More Information]
  • Baille, A., Sannibale, C., Stapinski, L., Teesson, M., Rapee, R., Haber, P. (2013). An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol. BMC Psychiatry, 13(7), 1-12. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Haber, P., Day, C. (2013). Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia. International Journal of Drug Policy, 24(4), 326-332. [More Information]
  • Alavi, M., Grebely, J., Micallef, M., Dunlop, A., Balcomb, A., Day, C., Treloar, C., Bath, N., Haber, P., Dore, G. (2013). Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study. Clinical Infectious Diseases, 57(Suppl 2), S62-S69. [More Information]
  • Lakshman, M., Garige, M., Gong, M., Leckey, L., Varatharajalu, R., Redman, R., Seth, D., Haber, P., Hirsch, K., Amdur, R., et al (2013). CYP2E1, Oxidative Stress, Post-translational Modifications and Lipid Metabolism. In Aparajita Dey (Eds.), Cytochrome P450 2E1: Its Role in Disease and Drug Metabolism, (pp. 199-233). Dordrecht: Springer Science + Business Media.
  • Morley, K., Baillie, A., Sannibale, C., Teesson, M., Haber, P. (2013). Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial. Addiction Science & Clinical Practice, 8, 1-8. [More Information]
  • Buckley, V., Razaghi, A., Haber, P. (2013). Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service. Australian and New Zealand Journal of Obstetrics and Gynaecology, 53(5), 464-470. [More Information]
  • Islam, M., Topp, L., Conigrave, K., Haber, P., White, A., Day, C. (2013). Sexually transmitted infections, sexual risk behaviours and perceived barriers to safe sex among drug users. Australian and New Zealand Journal of Public Health, 37(4), 311-315. [More Information]
  • Morley, K., Leung, S., Baillie, A., Haber, P. (2013). The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): Study protocol for a randomised controlled trial. Contemporary Clinical Trials, 36(2), 348-355. [More Information]

2012

  • Taylor, L., Hutchinson, D., Rapee, R., Burns, L., Stephens, C., Haber, P. (2012). Clinical Features and Correlates of Outcomes for High-Risk, Marginalized Mothers and Newborn Infants Engaged with a Specialist Perinatal and Family Drug Health Service. Obstetrics and Gynecology International, 2012, 1-8. [More Information]
  • Morley, K., Haber, P., Sitharthan, G., Tucker, P., Sitharthan, T. (2012). Clinical Predictors of Suicidal Behaviour Among Patients with Alcohol and/or Substance Abuse and Suicide Risk. APSAD Conference, Australasian Professional Society on Alcohol and other Drugs, Melbourne.
  • Deacon, R., Topp, L., Wand, H., Day, C., Rodgers, C., Haber, P., van Beek, I., Maher, L. (2012). Correlates of Susceptibility to Hepatitis B among People Who Inject Drugs in Sydney, Australia. Journal of Urban Health, 89(5), 769-778. [More Information]
  • Schwarz, B., Haber, P. (2012). Detection and management of problem drinking in general practice. Medicine Today, 13(7), 44-52.
  • Alavi, M., Grebely, J., Matthews, G., Petoumenos, K., Yeung, B., Day, C., Lloyd, A., van Beek, I., Kaldor, J., Hellard, M., Haber, P., et al (2012). Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection. Journal of Gastroenterology and Hepatology, 27(5), 957-965. [More Information]
  • Gidding, H., Law, M., Amin, J., Ostapowicz, G., Weltman, M., Macdonald, G., Sasadeusz, J., Haber, P., George, J., Dore, G. (2012). Hepatitis C treatment outcomes in Australian clinics. Medical Journal of Australia, 196(10), 633-637. [More Information]
  • Day, C., Demirkol, A., Tynan, M., Curry, K., Hines, S., Lintzeris, N., Haber, P. (2012). Individual versus team-based case-management for clients of opioid treatment services: An initial evaluation of what clients prefer. Drug and Alcohol Review, 31(4), 499-506. [More Information]
  • Islam, M., Topp, L., Conigrave, K., White, A., Reid, S., Grummett, S., Haber, P., Day, C. (2012). Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre. Journal of Substance Abuse Treatment, 43(4), 440-445. [More Information]
  • Black, K., Haber, P., Lintzeris, N. (2012). Offering incentives to drug-using women to take up contraception: The ethical and clinical issues. Addiction, 107(7), 1361-1362. [More Information]
  • Mofizul Islam, M., Reid, S., White, A., Grummett, S., Conigrave, K., Haber, P. (2012). Opportunistic and continuing health care for injecting drug users from a nurse-run needle syringe program-based primary health-care clinic. Drug and Alcohol Review, 31(1), 114-115. [More Information]
  • Morley, K., Haber, P., Morgan, M., Samara, F. (2012). Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Substance Abuse and Rehabilitation, 3, 43-47. [More Information]
  • Black, K., Stephens, C., Haber, P., Lintzeris, N. (2012). Unplanned pregnancy and contraceptive use in women attending drug treatment services. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(2), 146-150. [More Information]

2011

  • Mofizul Islam, M., Grummett, S., White, A., Reid, S., Day, C., Haber, P. (2011). A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health, 35(3), 294-295. [More Information]
  • Grebely, J., Matthews, G., Hellard, M., Shaw, D., van Beek, I., Petoumenos, K., Alavi, M., Yeung, B., Haber, P., Lloyd, A., et al (2011). Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of Hepatology, 55(1), 76-85. [More Information]
  • Day, C., Mofizul Islam, M., White, A., Reid, S., Hayes, S., Haber, P. (2011). Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Australian Journal of Primary Health, 17(1), 10-15. [More Information]
  • Haber, P. (2011). Gastrointestinal disorders related to alcohol and other drug use. In Christopher A. Cavacuiti (Eds.), Principles of Addiction Medicine: The Essentials, (pp. 0-0). United States: Lippincott Williams & Wilkins.
  • Haber, P. (2011). International perspectives in postgraduate medical training in addiction medicine. Substance Abuse, 32(2), 75-76. [More Information]
  • Haber, P., Batey, R. (2011). Liver disorders related to alcohol and other drug use. In Christopher A. Cavacuiti (Eds.), Principles of Addiction Medicine: The Essentials, (pp. 0-0). United States: Lippincott Williams & Wilkins.
  • Seth, D., Haber, P., Syn, W., Diehl, A., Day, C. (2011). Pathogenesis of alcohol-induced liver disease: Classical concepts and recent advances. Journal of Gastroenterology and Hepatology, 26(7), 1089-1105. [More Information]
  • Demirkol, A., Haber, P., Conigrave, K. (2011). Problem drinking - detection and assessment in general practice. Australian Family Physician, 40(8), 570-574. [More Information]
  • Demirkol, A., Conigrave, K., Haber, P. (2011). Problem drinking - management in general practice. Australian Family Physician, 40(8), 576-582. [More Information]
  • Burns, L., Conroy, E., Moore, E., Hutchinson, D., Haber, P. (2011). Psychosocial Characteristics and Obstetric Health of Women Attending a Specialist Substance Use Antenatal Clinic in a Large Metropolitan Hospital. International Journal of Pediatrics, 2011 (Article ID 729237), 1-7. [More Information]
  • Haber, P., Murnion, B. (2011). Training in Addiction Medicine in Australia. Substance Abuse, 32(2), 115-119. [More Information]
  • Lipworth, W., Wodak, A., Haber, P., Day, R. (2011). Why is Disulfiram not on the PBS? Medical Journal of Australia, 195(7), 371-372. [More Information]

2010

  • Seth, D., El-Guindy, N., Apte, M., Mari, M., Dooley, S., Neuman, M., Haber, P., Kundu, G., Darwanto, A., De Villiers, W., et al (2010). Alcohol, Signaling, and ECM Turnover. Alcoholism: Clinical and Experimental Research, 34(1), 1-15. [More Information]
  • Morley, K., Teesson, M., Sannibale, C., Baillie, A., Haber, P. (2010). Clinical Predictors of Outcome from an Australian Pharmacological Relapse Prevention Trial. Alcohol and Alcoholism, 45, 520-526. [More Information]
  • Dore, G., Hellard, M., Matthews, G., Grebely, J., Haber, P., Petoumenos, K., Yeung, B., Marks, P., van Beek, I., McCaughan, G., et al (2010). Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology, 138(1), 123-135.e1-2. [More Information]
  • Boonwaat, L., Haber, P., Levy, M., Lloyd, A. (2010). Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Medical Journal of Australia, 192(9), 496-500. [More Information]
  • Grebely, J., Petoumenos, K., Matthews, G., Haber, P., Marks, P., Lloyd, A., Kaldor, J., Dore, G., Hellard, M. (2010). Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug and Alcohol Dependence, 107(40239), 244-249. [More Information]
  • Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010). Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review, 29(5), 469-474. [More Information]
  • Dolan, K., Teutsch, S., Scheuer, N., Levy, M., Rawlinson, W., Kaldor, J., Lloyd, A., Haber, P. (2010). Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal Of Epidemiology, 25(2), 143-148. [More Information]
  • Teutsch, S., Luciani, F., Scheuer, N., McCredie, L., Hosseiny, P., Rawlinson, W., Kaldor, J., Dore, G., Dolan, K., Ffrench, R., Haber, P., et al (2010). Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health, 10(633), 1-9. [More Information]
  • Seth, D., Daly, A., Haber, P., Day, C. (2010). Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology, 51(4), 1463-1465. [More Information]
  • Teesson, M., Hall, W., Slade, T., Mills, K., Grove, R., Mewton, L., Baillie, A., Haber, P. (2010). Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction, 105(12), 2085-2094. [More Information]
  • Baillie, A., Stapinski, L., Crome, E., Morley, K., Sannibale, C., Haber, P., Teesson, M. (2010). Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders. Drug and Alcohol Review, 29(5), 518-524. [More Information]
  • Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010). The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction, 105(2), 329-334. [More Information]

2009

  • Haber, P., Neasham, K. (2009). Alcohol and Drug Abuse. In T Declan Walsh, Augusto T Caraceni, etal (Eds.), Palliative Medicine (2009), (pp. 451-458). United States: Saunders Elsevier.
  • Matthews, G., Hellard, M., Haber, P., Yeung, B., Marks, P., Baker, D., McCaughan, G., Sasadeusz, J., White, P., Rawlinson, W., et al (2009). Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C. Clinical Infectious Diseases, 48(5), 650-658. [More Information]
  • Leong, M., Murnion, B., Haber, P. (2009). Examination of Opioid Prescribing in Australia from 1992-2007. Internal Medicine Journal, 39(10), 676-681. [More Information]
  • Colagiuri, B., Morley, K., Boakes, R., Haber, P. (2009). Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psychotherapy and psychosomatics, 78(3), 167-171. [More Information]
  • Haber, P., Lintzeris, N., Proude, E., Lopatko,, O. (2009), Guidelines for the Treatment of Alcohol Problems. , , , 1-255.
  • Haber, P., Demirkol, A., Lange, K., Murnion, B. (2009). Management of injecting drug users admitted to hospital. The Lancet, 374(9697), 1284-1293. [More Information]
  • Day, C., Haber, P. (2009). Managing drug dependence in people with hepatitis C. In G. Dore, M. Temple-Smith, A. Lloyd (Eds.), Hepatitis C: An Expanding Perspective, (pp. 288-307). East Hawthorn, Victoria: IP Communications.
  • Haber, P., Lintzeris, N., Morley, K. (2009). Pharmacotherapies for alcohol dependence. In Paul Haber, Elizabeth Proude, Nick Lintzeris & Olga Lopatko (Eds.), Guidelines for the Treatment of Alcohol Problems, (pp. 93-106). Australia: Commonwealth of Australia.
  • Morley, K., Teesson, M., Sannibale, C., Haber, P. (2009). Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence. Drug and Alcohol Review, 28(3), 222-229.
  • Haber, P., Addolorato, G., Russell, M., Albano, E., Wands, J., Leggio, L. (2009). Understanding and Treating Patients With Alcoholic Cirrhosis: An Update. Alcoholism: Clinical and Experimental Research, 33(7), 1136-1144. [More Information]

2008

  • Devanshi, S., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2008). Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. Journal of Hepatology, 48(4), 614-627. [More Information]
  • Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008). Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol? Addiction, 103(6), 953-959. [More Information]
  • Gong, M., Castillo, L., Redman, R., Garige, M., Hirsch, K., Azuine, M., Amdur, R., Seth, D., Haber, P., Lakshmanan, M. (2008). Down-regulation of liver Galβ1, 4GlcNAc α2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans. Metabolism: clinical and experimental, 57(12), 1663-1668. [More Information]
  • Proude, E., Conigrave, K., Britton, A., Haber, P. (2008). Improving alcohol and tobacco history taking by junior medical officers. Alcohol and Alcoholism, 43(3), 320-325. [More Information]
  • Neuman, M., Sha, K., Esguerra, R., Zakhari, S., Winkler, R., Hilzenrat, N., Wyse, J., Cooper, C., Seth, D., Gorrell, M., Haber, P., McCaughan, G., et al (2008). Inflammation and Repair in Viral Hepatitis C. Digestive diseases and sciences, 53(6), 1468-1487. [More Information]
  • Thomson, C., Morley, K., Teesson, M., Sannibale, C., Haber, P. (2008). Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug and Alcohol Review, 27(2), 115-122. [More Information]
  • Lane, J., Proude, E., Conigrave, K., de Boer, J., Haber, P. (2008). Nurse-provided screening and brief intervention for risky alcohol consumption by sexual health clinic patients. Sexually Transmitted Infections, 84(7), 524-527. [More Information]
  • Dore, G., Haber, P. (2008). Tell me it ain't so: Patient-to-patient transmission of hepatitis C in an endoscopy clinic. Hepatology (Baltimore Md.), 48(4), 1333-5. [More Information]
  • Williams, G., Daly, M., Proude, E., Kermode, S., Davis, M., Barling, J., Haber, P. (2008). The influence of alcohol and tobacco use in orthopaedic inpatients on complications of surgery. Drug and Alcohol Review, 27(1), 55-64. [More Information]
  • Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J., Haber, P. (2008). Unplanned admissions to two Sydney public hospitals after naltrexone implants. Medical Journal of Australia, 188(8), 441-444. [More Information]

2007

  • Wurst, F., Haber, P., Wiesbeck, G., Watson, B., Wallace, C., Whitfield, J., Halter, C., Weinmann, W., Conigrave, K. (2007). Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study. Addiction Biology, doi:10.1111/j.1369-1600.2007.00076.x, 1-7. [More Information]
  • Shourie, S., Conigrave, K., Proude, E., Haber, P. (2007). Detection of and intervention for excessive alcohol and tobacco use among adult hospital in-patients. Drug and Alcohol Review, 26(2), 127-133. [More Information]
  • Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Vonghia, L., Mirijello, A., Abenavoli, L., D’Angelo, C., Caputo, F., Haber, P., et al (2007). Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. The Lancet, 370(9603), 1915-1922.
  • Watson, B., Conigrave, K., Wallace, C., Whitefield, J., Wurst, F., Haber, P. (2007). Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and Alcohol Review, 26(3), 231-239. [More Information]
  • Shourie, S., Conigrave, K., Proude, E., Ward, J., Wutzke, S., Haber, P. (2007). Pre-operative screening for excessive alcohol consumption among patients scheduled for elective surgery. Drug and Alcohol Review, 26(2), 119-125. [More Information]
  • Haber, P., Young, M., Dorrington, L., Jones, A., Kaldor, J., De Kanzow, S., Rawlinson, W. (2007). Transmission of hepatitis C virus by needle-stick injury in community settings. Journal of Gastroenterology and Hepatology, 22, 1882-1885. [More Information]
  • Haber, P., McCaughan, G., Shaw, D., Matthews, G., Hellard, M., Dore, G., Lloyd, A., Kaldor, J., Rowlinson, W., Ffrench, R. (2007). Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the australian trial in acute hepatitis C (ATAHC). The 58th Annual Meeting of the American Association for the Study of Liver Diseases, United States of America: John Wiley & Sons.

2006

  • Haber, P. (2006). Commentary: Challenge for doctors and policy makers. BMJ: British Medical Journal, 332, 277-278.
  • Proude, E., Conigrave, K., Haber, P. (2006). Effectiveness of skills-based training using the Drink-less package to increase family practitioner confidence in intervening for alcohol use disorders. BMC International Health and Human Rights, 6(8), 1-6. [More Information]
  • Seth, D., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2006). Identification of novel therapeutic targets for alcoholic liver disease. International Society for Biomedical Research on Alcoholism World congress on Alcohol Research (ISBRA 2006), Maryland: Wiley-Blackwell Publishing.
  • Seth, D., Gorrell, M., Cordoba, S., McCaughan, G., Haber, P. (2006). Intrahepatic gene expression in human alcoholic hepatitis. Journal of Hepatology, 45(2), 306-320. [More Information]
  • Morley, K., Teesson, M., Reid, S., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J., Richardson, K., Haber, P. (2006). Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction, 101(10), 1451-1462. [More Information]
  • Seth, D., Beard, M., Gorrell, M., McCaughan, G., Haber, P. (2006). Osteopontin: An early marker for alcoholic liver injury? Alcoholism: Clinical and Experimental Research, 30(s2), 89A-89A.
  • Kelly, M., Chick, J., Gribble, R., Gleeson, M., Holton, M., Winstanley, J., McCaughan, G., Haber, P. (2006). Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol and Alcoholism, 41(3), 278-283.
  • Shourie, S., Conigrave, K., Proude, E., Ward, J., Wutzke, S., Haber, P. (2006). The Effectiveness of a Tailored Intervention for Excessive Alcohol Consumption Prior to Elective Surgery. Alcohol and Alcoholism, 41(6), 643-649. [More Information]
  • Richardson, K., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Baillie, A., Haber, P. (2006). The effects of alcohol and naltrexone on craving and alcohol consumption. Alcoholism: Clinical and Experimental Research, 30(s2), 169A-169A.
  • Shackel, N., Seth, D., Haber, P., Gorrell, M., McCaughan, G. (2006). The hepatic transcriptome in human liver disease. Comparative Hepatology, 5, 6-6. [More Information]
  • Teesson, M., Morley, K., Reid, S., Sannibale, C., Thomson, C., Richardson, K., Haber, P. (2006). The influence of depression on pharmacotherapy for alcohol dependence. Alcoholism: Clinical and Experimental Research, 30(s2), 68A-68A.

2005

  • Watson, B., Haber, P., Conigrave, K., Whitfield, J., Wallace, C., Wurst, F. (2005). Alcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatment. Alcoholism: Clinical and Experimental Research, 29(S1), 32A-32A.
  • Wurst, F., Watson, B., Haber, P., Whitfield, J., Wallace, C., Lauer, J., Weinmann, W., Conigrave, K. (2005). Alcohol consumption patterns amongst hepatitis C positive people receiving opioid maintenance treatment. 24th Symposium of the Arbeitsgemeinschaft fur Neuropsychopharmakologie und Pharmakopsychiatrie, Germany: Georg Thieme Verlag.
  • Shourie, S., Haber, P., Boughton, R., Conigrave, K. (2005). Clinical implications of alcohol misuse for surgery. In Preedey V; Watson R (Eds.), Comprehensive handbook of alcohol related pathology, (pp. 337-348). United States: Academic Press Elsevier.
  • Seitz, H., Salaspuro, M., Savolainen, M., Haber, P., Ishii, H., Teschke, R., Moshage, H., Lieber, C. (2005). From alcohol toxicity to treatment. Alcoholism: Clinical and Experimental Research, 29(7), 1341. [More Information]
  • Conigrave, K., Proude, E., Haber, P., Wilson, H., Saunders, J. (2005). How to treat - alcohol problems. Australian Doctor, 35(9), 35-42.
  • Reid, S., Teesson, M., Sannibale, C., Matsuda, M., Haber, P. (2005). The Efficacy of Compliance Therapy in Pharmacotherapy for Alcohol Dependence: A Randomized Controlled Trial. Journal of Studies on Alcohol, 66(6), 833-841.
  • Theodorou, S., Haber, P. (2005). The medical complications of heroin use. Current Opinion in Psychiatry, 18(3), 257-263.

2004

  • Post, J., Pan, Y., Freeman, A., Harvey, C., White, P., Palladinetti, P., Haber, P., Marinos, G., Levy, M., Kaldor, J., et al (2004). Clearance Of Hepatitis C Viremia Associated With Cellular Immunity In The Absence Of Seroconversion In The Hepatitis C Incidence And Transmission In Prisons Study Cohort. The Journal of Infectious Diseases, 189(10), 1846-1855.
  • Proude, E., Shourie, S., Conigrave, K., Wutzke, S., Haber, P., Ward, J. (2004). Do Elective Surgery Patients Use The Internet To Look For Information About Their Condition? ANZ Journal of Surgery, 74(5), 304-307.
  • Haber, P. (2004). Genetic disorders in pancreatitis. Journal of Gastroenterology and Hepatology, 19(8), 939-939. [More Information]
  • Gates, J., Post, J., Kaldor, J., Pan, Y., Haber, P., Lloyd, A., Dolan, K. (2004). Risk Factors For Hepatitis C Infection And Perception Of Antibody Status Among Male Prison Inmates In The Hepatitis C Incidence And Transmission In Prisons Study Cohort, Australia. Journal of Urban Health, 81(3), 448-452.

2003

  • Post, J., Yong, W., Freeman, A., Harvey, C., White, P., Palladinetti, P., Marinos, G., Haber, P., Levy, M., Kaldor, J., et al (2003). Clearance of Hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the Hepatitis C incidence and transmission in prisons study cohort. The Journal of Infectious Diseases, 11, 1846-1855.
  • Seth, D., Leo, M., McGuinness, P., Lieber, C., Brennan, Y., Williams, R., Wang, X., McCaughan, G., Gorrell, M., Haber, P. (2003). Gene expression profiling of alcoholic liver disease in the Baboon (Papio hamadryas) and human liver. The American Journal of Pathology: cellular and molecular biology of disease, 163(6), 2303-2317.
  • Fucito, L., Gomes, B., Murnion, B., Haber, P. (2003). General practitioners' diagnostic skills and referral practices in managing patients with drug and alcohol-related health problems: implications for medical training and education programmes. Drug and Alcohol Review, 22(4), 417-424.
  • Haber, P., Conigrave, K., Wodak, A. (2003). NSW Alcohol Summit: getting a better grip on our favourite drug. Medical Journal of Australia, 11, 521-522.
  • Haber, P., Warner, R., Seth, D., Gorrell, M., McCaughan, G. (2003). Pathogenesis and management of alcoholic hepatitis. Journal of Gastroenterology and Hepatology, 18(12), 1332-1344.
  • Seth, D., Gorrell, M., McGuiness, P., Leo, M., Lieber, C., McCaughan, G., Haber, P. (2003). SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. Journal Of Biochemical and Biophysical Methods, 55(1), 53-66.
  • Conigrave, K., Davies, P., Haber, P., Whitfield, J. (2003). Traditional markers of excessive alcohol use. Addiction, 98(S2), 31-43.

2001

  • Haber, P., Nakamura, M., Tsuchimoto, K., Ishii, H., Keogh, G., Apte, M., Moran, C., Stewart, N., Crawford, D., Pirola, R., McCaughan, G., Ramm, G., Conigrave, K., et al (2001). Alcohol and the pancreas. Alcoholism: Clinical and Experimental Research, 25, 244S-250S.

To update your profile click here. For support on your academic profile contact .